Standard
Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency : MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. / Dahl, Morten; Nordestgaard, B G; Lange, P; Vestbo, J; Tybjaerg-Hansen, A.
In:
Clinical Chemistry, Vol. 47, No. 1, 01.2001, p. 56-62.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Dahl, M, Nordestgaard, BG, Lange, P, Vestbo, J & Tybjaerg-Hansen, A 2001, 'Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals', Clinical Chemistry, vol. 47, no. 1, pp. 56-62.
APA
Dahl, M., Nordestgaard, B. G., Lange, P., Vestbo, J., & Tybjaerg-Hansen, A. (2001). Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clinical Chemistry, 47(1), 56-62.
Vancouver
Dahl M, Nordestgaard BG, Lange P, Vestbo J, Tybjaerg-Hansen A. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clinical Chemistry. 2001 Jan;47(1):56-62.
Author
Dahl, Morten ; Nordestgaard, B G ; Lange, P ; Vestbo, J ; Tybjaerg-Hansen, A. / Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency : MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. In: Clinical Chemistry. 2001 ; Vol. 47, No. 1. pp. 56-62.
Bibtex
@article{c907d65120224831818c7e72d77a5061,
title = "Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals",
abstract = "We tested whether intermediate (MZ, SZ) and severe (ZZ) alpha(1)-antitrypsin deficiency affects lung function in the population at large.",
keywords = "Adult, Aged, Aged, 80 and over, Female, Genotype, Humans, Lung Diseases, Obstructive, Male, Middle Aged, Regression Analysis, Respiratory Function Tests, Severity of Illness Index, alpha 1-Antitrypsin Deficiency",
author = "Morten Dahl and Nordestgaard, {B G} and P Lange and J Vestbo and A Tybjaerg-Hansen",
year = "2001",
month = jan,
language = "English",
volume = "47",
pages = "56--62",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc.",
number = "1",
}
RIS
TY - JOUR
T1 - Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency
T2 - MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals
AU - Dahl, Morten
AU - Nordestgaard, B G
AU - Lange, P
AU - Vestbo, J
AU - Tybjaerg-Hansen, A
PY - 2001/1
Y1 - 2001/1
N2 - We tested whether intermediate (MZ, SZ) and severe (ZZ) alpha(1)-antitrypsin deficiency affects lung function in the population at large.
AB - We tested whether intermediate (MZ, SZ) and severe (ZZ) alpha(1)-antitrypsin deficiency affects lung function in the population at large.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Female
KW - Genotype
KW - Humans
KW - Lung Diseases, Obstructive
KW - Male
KW - Middle Aged
KW - Regression Analysis
KW - Respiratory Function Tests
KW - Severity of Illness Index
KW - alpha 1-Antitrypsin Deficiency
M3 - Journal article
C2 - 11148177
VL - 47
SP - 56
EP - 62
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 1
ER -
